反应详情

tert-Butyl {1-[4-(2-chloro-9H-imidazo[1,2-d]pyrido[2,3-b][1,4]benzodiazepin-3-yl)phenyl]cyclobutyl}carbamate (36.4 mg, 0.0708 mmol) was dissolved in DCM (1 mL). 4M HCl/dioxane (1 mL) was added to the mixture and stirred at room temperature for 15.5 hours. The mixture was concentrated and solidified with ether. The precipitated solids were collected by filtration and washed with ether to afford desired product (33.6 mg, 90.6%) as yellow solid. 1H NMR (DMSO-d6) 400 MHz δ: 8.72 (br s, 2H), 8.68 (s, 1H), 8.16 (dd, J=4.8, 1.8 Hz, 1H), 7.82 (dd, J=7.8, 1.8 Hz, 1H), 7.61-7.55 (m, 2H), 7.42-7.27 (m, 4H), 7.13-7.07 (m, 1H), 6.98 (dd, J=7.8, 1.8 Hz, 1H), 6.81 (dd, J=7.8, 4.8 Hz, 1H), 4.27 (br s, 3H), 2.64-2.43 (m, 4H), 2.26-2.12 (m, 1H), 1.89-1.74 (m, 1H); LCMS: 414 [M+H].

1. concentrationThe mixture was concentrated
2. filtrationThe precipitated solids were collected by filtration
3. washwashed with ether